Interaction of PTH and PTHrP with Their Receptors

Reviews in Endocrine and Metabolic Disorders

Volumn 1, Issue 4, 2000, Pages 317-329

  Gardella, Thomas J ^a   Jüppner, Harald ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

G protein coupled receptor; Parathyroid hormone; Parathyroid hormone related peptide; Peptide hormone family; Photochemical crosslinking; Receptor binding; Receptor mutagenesis; Signal transduction; Structure activity relationship

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; GENETICS; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PARATHYROID HORMONE; RECEPTORS, PARATHYROID HORMONE; SIGNAL TRANSDUCTION;

EID: 0034332472     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026522619828     Document Type: Article

References (82)

1. Kronenberg HM, Bringhurst FR, Nussbaum S, Jüppner H, Abou-Samra AB, Segre GV, Potts JT, Jr. Parathyroid hormone: Biosynthesis, secretion, chemistry and action. In: Mundy GR, Martin TJ, eds. Handbook of Experimental Pharmacology: Physiology and Pharmacology of Bone. Heidelberg, Germany: Springer-Verlag, 1993;185-201.
2. Potts JT Jr, Jüppner H. Parathyroid hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism and bone development: the proteins, their genes and receptors. In: Avioli LV, Krane SM, eds., 3 ed. Metabolic Bone Disease. New York: Academic Press, 1997;51-94.
3. 2+-sensing receptor from bovine parathyroid. Nature 1993;366:575-580.
4. Broadus AE, Stewart AF. Parathyroid hormone-related protein: Structure, processions and physiological action. In: Bilezikian JP, Levine MA, Marcus R, eds. The parathyroids. Basic and Clinical Concepts. New York: Raven Press, 1994;259-294.
5. Karaplis AC, Luz A, Glowacki J, Bronson R, Tybulewicz V, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Develop 1994;8:277-289.
6. Lanske B, Karaplis AC, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Jüppner H, Segre GV, Kronenberg HM. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996;273:663-666.
7. Kemp BE, Mosely JM, Rodda CP, Ebeling PR, Wettenhall REH, Stapleton D, Diefenbach-Jagger H, Ure F, Michelangali VP, Simmons HA, Raisz LG, Martin TJ. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 1987;238:1568-1570.
8. Tregear GW, Van Rietschoten J, Greene E, Keutmann HT, Niall HD, Reit B, Parsons JA, Potts JT, Jr. Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology 1973;93:1349-1353.
9. Horiuchi N, Holick MF, Potts JT Jr, Rosenblatt M. A parathyroid hormone inhibitor in vivo: design and biologic evaluation of a hormone analog. Science 1983;220:1053-1055.
10. 2 by substitution of PTH amino acids at positions 10 and 11. Endocrinology 1990;127:491-493.
11. Takasu H, Gardella T, Luck M, Potts Jr J, Bringhurst F. Amino-Terminal Modifications of Human Parathyroid Hormone(PTH) Selectively Alter Phospholipase C Signaling via the Type 1 PTH Receptor: Implications for Design of Signal-Specific PTH Ligands. Biochemistry 1999;38:13453-13460.
12. Jouishomme H, Whitfield JF, Gagnon L, Maclean S, Isaacs R, Chakravarthy B, Durkin J, Neugebauer W, Willick G, Rixon RH. Further definition of the protein kinase C activation domain of the parathyroid hormone. J Bone Miner Res 1994;9:943-949.
13. Azarani A, Goltzman D, Orlowski J. Structurally diverse N-terminal peptides of parathyroid hormone (PTH) and PTH-related peptide (PTHRP) inhibit the Na+/H+ exchanger NHE3 isoform by binding to the PTH/PTHRP receptor type I and activating distinct signaling pathways. J Biol Chem 1996;271:14931-14936.
14. Takasu H, Bringhurst FR. Type-1 parathyroid hormone (PTH)/ PTH-related peptide (PTHrP) receptors activate phospholipase C in response to carboxyl-truncated analogs of PTH(1-34). Endocrinology 1998;139:4293-4299.
15. Friedman PA, Gesek FA, Morley P, Whitfield JF, Willick GE. Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells. Endocrinology 1999;140:301-309.
16. Caulfield MP, McKee RL, Goldman ME, Duong LT, Fisher JE, Gay CT, DeHaven PA, Levy JJ, Roubini E, Nutt RF, Chorev M, Rosenblatt M. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. Endocrinology 1990;127:83-87.
17. Nussbaum SR, Rosenblatt M, Potts JT Jr. Parathyroid hormone/ renal receptor interactions: demonstration of two receptor-binding domains. J Biol Chem 1980;255:10183-10187.
18. Abou-Samra A-B, Uneno S, Jüppner H, Keutmann H, Potts JT, Jr, Segre GV, Nussbaum SR. Non-homologous sequences of parathyroid hormone and the parathyroid hormone related peptide bind to a common receptor on ROS 17/2.8 cells. Endocrinology 1989;125:2215-2217.
19. Jüppner H, Schipani E, Bringhurst FR, McClure I, Keutmann HT, Potts JT, Jr, Kronenberg HM, Abou-Samra AB, Segre GV, Gardella TJ. The extracellular, amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor determines the binding affinity for carboxyl-terminal fragments of PTH(1-34). Endocrinology 1994;134:879-884.
20. Goltzman D, Peytremann A, Callahan E, Tregear GW, Potts JT, Jr. Analysis of the Requirements for Parathyroid Hormone Action in Renal Membranes with the Use of Inhibiting Analogues. J Biol Chem 1975;250:3199-3203.
21. Carter P, Juppner H, Gardella T. Studies of the N-terminal region of a parathyroid hormone-related peptide(1-36) analog: receptor subtype-selective agonists, antagonists and photochemical cross-linking agents. Endocrinology 1999;140:4972-4981.
22. Cohen FE, Strewler GJ, Bradley MS, Carlquist M, Nilsson M, Ericsson M, Ciardelli TL, Nissenson RA. Analogues of parathyroid hormone modified at postions 3 and 6: effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J Biol Chem 1991;266:1997-2004.
23. Gardella TJ, Axelrod D, Rubin D, Keutmann HT, Potts JT, Jr, Kronenberg HM, Nussbaum SR. Mutational analysis of the receptor-activating region of human parathyroid hormone. J Biol Chem 1991;266:13141-13146.
24. Behar V, Bisello A, Bitan B, Rosenblatt M, Chorev M. Photoaffinity cross-linking identifies differences in the interactions of an Agonist and an antagonist with the parathyroid hormone/ parathyroid hormone-related protein receptor. J Biol Chem 1999;275:9-17.
25. Marx UC, Austermann S, Bayer P, Adermann K, Ejchart A, Sticht H, Walter S, Schmid F-X, Jaenicke R, Forssmann W-G, Rosch P. Structure of human parathyroid hormone 1-37 in solution. J Biol Chem 1995;270:15194-15202.
26. Barden JA, Kemp BE. NMR solution structure of human parathyroid hormone(1-34). Biochemistry 1993;32:7126-7132.
27. Pellegrini M, Royo M, Rosenblatt M, Chorev M, Mierke D. Addressing the tertiary structure of human parathyroid hormone-(1-34). J Biol Chem 1998;273:10420-10427.
28. Weidler M, Marx UC, Seidel G, Schafer W, Hoffmann E, Ebwein A, Rosch P. The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution. Febs Letters 1999;444:239-244.
29. Barden J, Cuthbertson R, Jia-Zhen W, Moseley J, Kemp B. Solution structure of parathyroid hormone related protein (residues 1-34) containing an Ala substituted for an Ile in position 15 (PTHrP[Ala15]-(1-34)). J Biol Chem 1997;273:29572-29578.
30. Gardella TJ, Luck MD, Wilson AK, Keutmann HT, Nussbaum SR, Potts JT Jr, Kronenberg HM. Parathyroid hormone (PTH)/PTH-related peptide hybrid peptides reveal functional interactions between the 1-14 and 15-34 domains of the ligand. J Biol Chem 1995;270:6584-6588.
31. Neugebauer W, Surewicz WK, Gordon HL, Somorjai RL, Sung W, Willick GE. Structural elements of human parathyroid hormone and their possible relation to biological activities. Biochemistry 1992;31:2056-2063.
32. Pellegrini M, Bisello A, Rosenblatt M, Chorev M, Mierke DF. Binding domain of human parathyroid hormone receptor: from conformation to function. Biochemistry 1998;37:12737-12743.
33. Neugebauer W, Barbier JR, Sung WL, Whitfield JF, Willick GE. Solution structure and adenylyl cyclase stimulating activities of C-terminal truncated human parathyroid hormone analogues. Biochemistry 1995;34:8835-8842.
34. Gardella TJ, Wilson AK, Keutmann HT, Oberstein R, Potts JT, Jr, Kronenberg HM, Nussbaum SR. Analysis of parathyroid hormone's principal receptor-binding region by site directed mutagenesis and analog design. Endocrinology 1993;132:2024-2030.
35. Jüppner H, Abou-Samra AB, Freeman MW, Kong XF, Schipani E, Richards J, Kolakowski LF, Jr., Hock J, Potts JT, Jr., Kronenberg HM, Segre GV. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991;254:1024-1026.
36. Kolakowski LFJ. GCRDb: A G-protein-coupled receptor database. Receptors and Channels 1994;2:1-7. http://www.gcrdb.uthscsa.edu/
37. Zhang P, Jobert AS, Couvineau A, Silve C. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 1998;83:3373-3376.
38. Karaplis A, He B, Nguyen M, Young I, Semeraro D, Ozawa H, Amizuka N. Inactivating mutation in the human PTH receptor type 1 gene in blomstrand chondrodysplasia. Endocrinology 1998;139:5255-5258.
39. Gardella TJ, Luck MD, Fan M-H, Lee CW. Transmembrane residues of the parathyroid hormone (PTH)/PTH-related peptide receptor that specifically affect binding and signaling by agonist ligands. J Biol Chem 1996;271:12820-12825.
40. Hamann J, Eichler W, Hamann D, Kerstens HMJ, Poddighe PJ, Hoovers JMN, Hartmann E, Strauss M, van Lier RAW. Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretin receptor superfamily with an unusual extracellular domain. J. Immunol. 1995;155:1942-1950.
41. Krasnoperov VG, Bittner MA, Beavis R, Kuang Y, Salnikow KV, Chepurny OG, Little AR, Plotnikov AN, Wu D, Holz RW, Petrenko AG. alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 1997;18:925-937.
42. Donnelly D. The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors. FEBS Lett 1997;409:431-436.
43. Rolz C, Pellegrini M, Mierke DF. Molecular characterization of the receptor-ligand complex for parathyroid hormone. Biochemistry 1999;38:6397-6405.
44. Mannstadt M, Luck M, Gardella TJ, Jüppner H. Evidence for a ligand interaction site at the amino-terminus of the PTH/PTHrP receptor from crosslinking and mutational studies. J Biol Chem 1998;273:16890-16896.
45. Bergwitz C, Gardella TJ, Flannery MR, J T Potts J, Kronenberg HM, Goldring SR, Jüppner H. Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. J Biol Chem 1996;271:26469-26472.
46. Stroop SD, Kuestner RE, Serwold TF, Chen L, Moore EE. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry 1995;34:1050-1057.
47. Dong M, Wang Y, Pinon D, Hadac E, Miller L. Demonstration of a Direct interaction between residue 22+ in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. J Biol Chem 1999;274:903-909.
48. Lee C, Luck MD, Jüppner H, Potts JT, Jr., Kronenberg HM, Gardella TJ. Homolog-scanning mutagenesis of the parathyroid hormone (PTH) receptor reveals PTH-(1-34) binding determinants in the third extracellular loop. Molecular Endocrinology 1995;9:1269-1278.
49. Adams A, Bisello A, Chorev M, Rosenblatt M, Suva L. Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone. Molecular Endocrinology 1998;12:1673-1683.
50. Carter P, Shimizu M, Luck M, Gardella T. The hydrophobic residues phenylalanine 184 and leucine 187 in the type-1 parathyroid hormone (PTH) receptor functionally interact with the amino-terminal portion of PTH (1-34). J Biol Chem 1999;274:31955-31960.
51. 2]PTH-(1-34) binding and signaling in the transmembrane region of the parathyroid hormone receptor. Endocrinology 1994;135:1186-1194.
52. Bisello A, Adams AE, Mierke DF, Pellegrini M, Rosenblatt M, Suva LJ, Chorev M. Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem 1998;273:22498-22505.
53. Lee C, Gardella TJ, Abou-Samra AB, Nussbaum SR, Segre GV, Potts JT, Jr., Kronenberg HM, Jüppner H. Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding. Endocrinology 1994;135:1488-1495.
54. Greenberg Z, Bisello A, Rosenblatt M, Chorev M. Identification of a novel contact domain between a residue in the principal binding domain of parathyroid hormone (PTH) and the first extracelular loop of the PTH-1 receptor. JBMR 1999;14:F393
55. Luck M, Carter P, Gardella T. The [1-14] Fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. Molecular Endocrinology 1999;13:670-680.
56. Shimizu M, Potts JJ, Gardella T. Minimization of parathyroid hormone. J Biol Chem. 2000;275:21836-21843.
57. Gether U, Kobilka BK. G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 1998;273:17979-17982.
58. Behar V, Nakamoto C, Greenberg Z, Bisello A, Suva LJ, Rosenblatt M, Chorev M. Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes. Endocrinology 1996;137:4217-4224.
59. Gardella TJ, Luck MD, Jensen GS, Usdin TB, Jüppner H. Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist. J Biol Chem 1996;271:19888-19893.
60. Turner PR, Bambino T, Nissenson RA. Mutations of neighboring polar residues on the second transmembrane helix disrupt signaling by the parathyroid hormone receptor. Mol Endocrinol 1996;10:132-139.
61. Usdin TB, Gruber C, Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 1995;270:15455-15458.
62. Hoare SR, Bonner TI, Usdin TB. Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor. Endocrinology 1999;140:4419-4425.
63. Usdin TB. Tip39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nature Neuroscience 1999;2:941-943.
64. Bergwitz C, Jusseaume SA, Luck MD, Jüppner H, Gardella TJ. Residues in the membrane-spanning and extracellular regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. J Biol Chem 1997;272:28861-28868.
65. Turner PR, Mefford S, Bambino T, Nissenson RA. Transmembrane residues together with the amino-terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide. J Biol Chem 1998;273:3830-3837.
66. Ji TH, Grossmann M, Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 1998;273:17299-17302.
67. Iida-Klein A, Guo J, Takemura M, Drake MT, Potts JT, Jr., Abou-Samra A, Bringhurst FR, Segre GV. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem 1997;272:6882-6889.
68. 2++ signal transduction pathways. J Biol Chem 1996;271:33382-33389.
69. Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana HG. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 1996;274:768-770.
70. Sheikh SP, Vilardarga JP, Baranski TJ, Lichtarge O, Iiri T, Meng EC, Nissenson RA, Bourne HR. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. J Bio Chem 1999;274:17033-17041.
71. Schipani E, Kruse K, Jüppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995;268:98-100.
72. Schipani E, Jensen GS, Pincus J, Nissenson RA, Gardella TJ, Jüppner H. Constitutive activation of the cAMP signaling pathway by parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia. Mol Endocrinol 1997;11:851-858.
73. Schipani E, Langman C, Hunzelman J, Le Merrer M, Loke K, Dillon MJ, Silve C, Jüppner H. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endo Metab 1999;84:3052-3057.
74. Gardella TJ, Luck MD, Jensen GS, Schipani E, Potts JT Jr, Jüppner H. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors linked to Jansen's metaphyseal chondrodysplasia. Endocrinology 1996;137:3936-3941.
75. Rubin DA, Jüppner H. Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide (PTH1R) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. J Biol Chem 1999;84:28185-28190.
76. Inomata N, Akiyama M, Kubota N, Jüppner H. Characterization of a novel PTH-receptor with specificity for the carboxyl-terminal region of PTH(1-84). Endocrinology 1995;136:4732-4740.
77. Kaji H, Sugimoto T, Kanatani M, Miyauchi A, Kimura T, Sakakibara S, Fukase M, Chihara K. Carboxyl-terminal PTH fragments stimulate osteoclast-like cell formation and osteoclastic activity. Endocrinology 1994;134:1897-1904.
78. Wu TL, Vasavada RC, Yang K, Massfelder T, Ganz M, Abbas SK, Care AD, Stewart AF. Structural and physiological characterization of the mid-region secretory species of parathyroid hormone-related protein. J Biol Chem 1996;271:24371-24381.
79. Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, Kronenberg HM. Parathyroid hormone-related peptide (PTHrP) regulates fetal placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci USA 1996;93:15233-15238.
80. Fenton AJ, Kemp BE, Hammonds RG, Jr., Mitchelhill K, Moseley JM, Martin TJ, Nicholson GC. A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. Endocrinology 1991;129:3424-3426.
81. Orloff JJ, Kats Y, Urena P, Schipani E, Vasavada RC, Philbrick WM, Behal A, Abou-Samra AB, Segre GV, Jüppner H. Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. Endocrinology 1995;136:3016-3023.
82. Gaich G, Orloff JJ, Atillasoy EJ, Burtis WJ, Ganz MB, Stewart AF. Amino-terminal parathyroid hormone-related portein: specific binding and cytosolic calcium responses in rat insulinoma cells. Endocrinology 1993;132:1402-1409.